Vorinostat targets UBE2C to reverse epithelial-mesenchymal transition and control cervical cancer growth through the ubiquitination pathway
Botao Pan, Shuanghong Yin, Fang Peng, Chang Liu, Huiyi Liang, Jiyan Su, W.L. Wendy Hsiao, Yantao Cai, Dixian Luo, Chenglai Xia
Topics & Concepts
VorinostatEpithelial–mesenchymal transitionVimentinCancer researchDownregulation and upregulationHistone deacetylase inhibitorHeLaCervical cancerCell growthCancerBiologyHistone deacetylaseChemistryCellHistoneImmunologyBiochemistryGeneticsImmunohistochemistryGeneHistone Deacetylase Inhibitors ResearchEpigenetics and DNA MethylationCancer Mechanisms and Therapy